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Abstract
Human T-cell leukemia virus type 1 (HTLV-1) is an etiological agent of several inflammatory
diseases and a T-cell malignancy, adult T-cell leukemia (ATL). HTLV-1 bZIP factor (HBZ) is
the only viral gene that is constitutively expressed in HTLV-1-infected cells, and it has multi-
ple functions on T-cell signaling pathways. HBZ has important roles in HTLV-1-mediated
pathogenesis, since HBZ transgenic (HBZ-Tg) mice develop systemic inflammation and T-
cell lymphomas, which are similar phenotypes to HTLV-1-associated diseases. We showed
previously that in HBZ-Tg mice, HBZ causes unstable Foxp3 expression, leading to an
increase in regulatory T cells (Tregs) and the consequent induction of IFN-γ-producing
cells, which in turn leads to the development of inflammation in the mice. In this study, we
show that the severity of inflammation is correlated with the development of lymphomas in
HBZ-Tg mice, suggesting that HBZ-mediated inflammation is closely linked to oncogenesis
in CD4+ T cells. In addition, we found that IFN-γ-producing cells enhance HBZ-mediated
inflammation, since knocking out IFN-γ significantly reduced the incidence of dermatitis as
well as lymphoma. Recent studies show the critical roles of the intestinal microbiota in the
development of Tregs in vivo. We found that even germ-free HBZ-Tg mice still had an
increased number of Tregs and IFN-γ-producing cells, and developed dermatitis, indicating
that an intrinsic activity of HBZ evokes aberrant T-cell differentiation and consequently
causes inflammation. These results show that immunomodulation by HBZ is implicated in
both inflammation and oncogenesis, and suggest a causal connection between HTLV-1-
associated inflammation and ATL.
Author Summary
HTLV-1 is a retrovirus which causes a cancer, ATL, and inflammatory diseases of several
tissues, such as the spinal cord, eye, skin, and lung. Although these HTLV-1-mediated
malignant and inflammatory diseases are recognized as distinct pathological entities, an
increased number of HTLV-1 infected cells and enhanced migration/infiltration of
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infected cells into the lesions are common features of these diseases. Indeed, several clinical
observations have suggested a causal link between inflammation and ATL (see Discus-
sion). In order to investigate this issue, appropriate animal models are indispensable.
Among HTLV-1-encoded regulatory/accessory proteins, HTLV-1 bZIP factor (HBZ) is
thought to be critical to HTLV-1-mediated pathogenesis. We previously reported that
HBZ transgenic (HBZ-Tg) mice which express HBZ in CD4+ T cells developed both sys-
temic inflammation and T-lymphomas, indicating that they are suitable to evaluate the
link, if any, between these phenomena. In this study, we generated several new genetically
engineered strains by modifying HBZ-Tg mice, and found that IFN-γ is an accelerator of
HBZ-induced inflammation. Importantly, we show that the incidence of inflammation is
correlated with that of lymphomagenesis in HBZ-Tg. These findings indicate that modifi-
cation of T-cell machinery by HBZ is closely associated with both HTLV-1-associated
inflammatory diseases and ATL.
Introduction
Human T-cell leukemia virus type 1 (HTLV-1) infects to mainly CD4+ T cells [1], and the pro-
virus is known to exist in effector/memory T cell and regulatory T cell (Treg) subsets [2, 3].
HTLV-1 induces clonal expansion of infected cells and consequently causes a malignancy of
CD4+CD25+ T cells, adult T-cell leukemia (ATL) [1]. This virus also gives rise to inflammatory
diseases including HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP),
HTLV-1 uveitis (HU), dermatitis, and HTLV-1-associated bronchoalveolitis (HABA)—dis-
eases which are characterized by infiltration of T cells into the lesions [4–7]. In addition, the
incidence of several infectious diseases, e.g., infective dermatitis [8] and strongyloidiasis [9], is
higher in HTLV-1 carriers than uninfected individuals, suggesting the presence of HTLV-
1-mediated cellular immunodeficiency. These findings indicate that HTLV-1 modifies the
immunophenotypes of T cells in the host, and these diseases are induced or promoted by aber-
rant action of infected T cells. Importantly, some clinical observations imply that in HTLV-
1-infected subjects, inflammation accelerates ATL development [10, 11], although a molecular
basis connecting inflammation to leukemogenesis has not yet been elucidated. In order to
understand the causal link between them, suitable animal models are necessary.
The HTLV-1 provirus encodes several regulatory/accessory genes in its pX region [12].
Among them, tax and HTLV-1 bZIP factor (HBZ), which are encoded in the plus- and minus-
strand of the pX region respectively, are thought to be important in pathogenesis. HBZ is the
only viral gene that is genetically conserved and constitutively expressed in ATL cells [13],
whereas Tax is often inactivated by transcriptional silencing or genetic mutations [14, 15].
Moreover, HBZ-transgenic (HBZ-Tg) mice that express HBZ in CD4+ T cells develop systemic
inflammatory diseases, cellular immunodeficiency, and T-cell lymphomas, suggesting that
HBZ plays important roles in HTLV-1-mediated pathogenesis [16, 17]. In HBZ-Tg, the num-
ber of CD4+CD25+ T cells and effector/memory CD4+ T cells are increased as same as ATL
cases [3]. Considering the similarities between phenotypes of HBZ-Tg mice and the clinical
features of HTLV-1-infected individuals, the HBZ-Tg mouse model is useful for investigating
the mechanisms of pathogenesis by HTLV-1.
We reported previously that the number of induced Tregs (iTregs) was increased in
HBZ-Tg mice through upregulation of Foxp3, which is a master gene of Tregs [18]. On the
other hand, expression of Foxp3 in HBZ-expressing iTregs is easily lost, whereupon these cells
convert to IFN-γ-producing cells that are called exFoxp3 cells [19]. We hypothesized that the
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increase in iTregs and the concurrent induction of IFN-γ-producing cells are implicated in
HBZ-mediated pathogenesis in vivo.
In this study, we focused on the significance of IFN-γ in HBZ-induced inflammation and
lymphoma, and established HBZ-Tg/IFN-γ knock out (KO) mice. The incidence of dermatitis
was significantly lower in HBZ-Tg/IFN-γ KOmice than HBZ-Tg mice, and importantly,
HBZ-Tg/IFN-γ KO mice developed no T-lymphomas. In addition, since the intestinal micro-
biota have important roles in the development and proliferation of iTregs [20], we generated
germ-free (GF) HBZ-Tg mice to evaluate the impact of the intestinal microbiota on the
increase in Tregs. Even in aseptic circumstances, HBZ-Tg mice developed dermatitis and had
the same pattern of T-cell immunophenotypes as specific pathogen free (SPF) HBZ-Tg mice,
suggesting that HBZ causes inflammation in a cell intrinsic manner. We also found that the
severity of dermatitis correlates with the development of lymphoma in HBZ-Tg mice. These
results suggest a close link between inflammation and oncogenesis in HBZ-Tg mice, and
demonstrate the important role of IFN-γ in the molecular mechanism of HBZ-mediated
pathogenesis.
Results
IFN-γ is involved in the inflammation and lymphomagenesis caused by
HBZ
In order to analyze the impact of IFN-γ on HBZ-mediated pathogenesis, we crossed HBZ-Tg
mice with IFN-γ KOmice to establish HBZ-Tg/IFN-γ KOmice (S1 Fig) [21]. We found that
some HBZ-Tg mice developed dermatitis at only 8 weeks of age, and 90% of HBZ-Tg mice
developed dermatitis within 2 years (Fig 1A and 1B), and these results are consistent with our
previous observations [16]. In contrast, HBZ-Tg/IFN-γ KOmice did not suffer from dermatitis
until 19 weeks or older, and after 2 years, only 50% of these mice had developed the skin disease
(Fig 1B).
To evaluate the presence of systemic inflammation, we performed histological analysis of
multiple organs from ten mice of each genotype at 24 weeks of age. The analysis revealed that
30% of HBZ-Tg mice showed infiltration of lymphocytes into the skin at the time point of anal-
ysis, whereas no HBZ-Tg/IFN-γ KOmice showed any abnormalities (Fig 1C and Table 1). Our
previous study also showed that HBZ-Tg mice which became moribund had lymphomas [16].
Surprisingly, we found that 30% of HBZ-Tg mice had already developed lymphomas in spleen
and lymph nodes at 24 weeks of age—earlier than we had guessed—and more importantly, the
severity of inflammation correlated with lymphoma development (Fig 1D and Table 1). In con-
trast, no HBZ-Tg/IFN-γ KOmice had lymphoma. These data strongly suggest that IFN-γ has
an important role in inflammation and lymphoma caused by HBZ, and that inflammation
might accelerate oncogenesis in HBZ-expressing T cells.
Foxp3+CD4+ T cells and effector/memory T cells are increased in both
HBZ-Tg and HBZ-Tg/IFN-γ KOmice
The numbers of Foxp3+CD4+ T cells and effector/memory T cells are increased in HBZ-Tg
[16]. To evaluate the influence of IFN-γ on CD4+ T cells, we performed flow cytometry and
compared the patterns of T-cell subsets between HBZ-Tg and HBZ-Tg/IFN-γ KO mice. CD4+
T cells from HBZ-Tg/IFN-γ KOmice expressed Foxp3 at similar level to that of HBZ-Tg mice
(Fig 2A and 2B and S2 Fig). Likewise, the effector/memory population was increased in
HBZ-Tg/IFN-γ KO mice (Fig 2A and 2B and S2 Fig), indicating that these changes in CD4+
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T-cell subset populations in HBZ-Tg mice are independent of IFN-γ production and not
directly correlated with the inflammatory phenotypes of the HBZ-Tg mice.
Next, we analyzed the production of inflammatory cytokines. Splenic T cells from 24-week-
old mice were stimulated by phorbol myristate acetate (PMA)/ionomycin and the expression
of IL-17, TNF-α, IL-2, IL-4 and IFN-γ in CD4+ T cells was evaluated by flow cytometry. IFN-γ
production was clearly increased in HBZ-Tg mice. Production of IL-17 and IL-2 were also
increased in both HBZ-Tg and HBZ-Tg/IFN-γ KOmice (Fig 2C and 2D and S2 Fig). These
findings show that loss of IFN-γ does not affect the production of these inflammatory cytokines
by HBZ-expressing CD4+ T cells.
Germ-free HBZ-Tg mice didn’t show any phenotypic differences from
SPF HBZ-Tg mice
Recently, it has been reported that iTregs are most abundant in the colonic mucosa in mice,
and that the number of mucosal Tregs is remarkably decreased in germ-free mice, indicating
that the gut microbiota has important roles in the development and proliferation of iTregs
[20]. Since both HBZ-Tg and HBZ-Tg/IFN-γ KOmice demonstrate increased numbers of
Fig 1. Incidence of inflammation and lymphoma is decreased in HBZ-Tg/IFN-γ KOmice. (A) HBZ-Tg and HBZ-Tg/IFN-γ KOmice at 24 weeks of age.
HBZ-Tg mice developed dermatitis around the ears, eyes, and back. HBZ-Tg/IFN-γ KOmice did not develop dermatitis. (B) 90% of HBZ-Tg developed
dermatitis by 2 years of age. However, in HBZ-Tg/IFN-γ KOmice, the onset of dermatitis was delayed and its incidence was lower than in HBZ-Tg mice.
*** indicates significant differences p<0.01. (C) Histological analysis of HBZ-Tg and HBZ-Tg/IFN-γ KOmice (x10). The spleen of an HBZ-Tg mouse shows a
diminution of the structure and a diffuse infiltration of atypical cells in red palps. The lymph node of HBZ-Tg shows a focal diminution of nodal structures and a
diffuse infiltration of atypical cells in paracortical area. The skin of HBZ-Tg shows hyperkeratosis of epidermis. However, the spleen, lymph node and skin of
HBZ-Tg/IFN-γ KO show normal structures. (D) Lymphomas developed in spleen and lymph nodes of HBZ-Tg mice with dermatitis. In the high magnification
(x60), the spleen of an HBZ-Tg mouse shows a diffuse infiltration of atypical large lymphoid cells with irregular nuclei, and the lymph node shows atypical
large lymphoid cells, also. Abnormal cells are indicated by white arrows.
doi:10.1371/journal.ppat.1005120.g001
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iTregs, we asked if the microbiota affected HBZ-mediated iTreg expansion and subsequent
inflammation as an extrinsic factor. In order to analyze the impact of microbiota on HBZ-
mediated pathogenesis, we generated the germ-free (GF) HBZ-Tg mice, which are genetically
the same as the HBZ-Tg mice we reported previously [16]. Contrary to our expectation, these
GF HBZ-Tg mice were phenotypically no different than regular HBZ-Tg mice maintained in
SPF conditions. The GF HBZ-Tg mice started developing skin inflammation as early as 9
Table 1. Histological findings in WT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice at 24 weeks of age.
Dermatitis Spleen Skin LN
WT #1 - - - -
#2 - - - -
#3 - - - -
#4 - - - -
#5 - - - -
#6 - - - -
#7 - Congestion - -
#8 - - - -
#9 - - - -
#10 - - - -
HBZ-Tg #1 - Congestion - Atypical lymphocyte
#2 - - - -
#3 +++ Lymphoma ++ Lymphoma
#4 +++ Lymphoma ++ Lymphoma
#5 ++ Lymphoma + Lymphoma
#6 ++ Congestion - Atypical lymphocyte
#7 + - - -
#8 + - - -
#9 + - - -
#10 - - - -
IFN-γ KO #1 - - - -
#2 - - - -
#3 - - - -
#4 - - - -
#5 - - - -
#6 - - - -
#7 - - - -
#8 - - - -
#9 - - - -
#10 - - - -
HBZ-Tg/IFN-γ KO #1 - - - -
#2 - - - -
#3 - - - -
#4 - - - -
#5 - - - -
#6 - - - -
#7 - - - -
#8 - - - -
#9 - - - -
#10 - - - -
doi:10.1371/journal.ppat.1005120.t001
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weeks of age, and 16 of 28 (57%) GF HBZ-Tg mice suffered from dermatitis by 18 weeks of age
(Fig 3A). Regarding the phenotypes of T cells, there were no significant differences between GF
and SPF HBZ-Tg; the number of both effector/memory T cells and Tregs were higher than
those in nontransgenic littermates, and the production of IFN-γ was upregulated in HBZ-Tg in
both settings (Fig 3B and 3C and S3 Fig). These results imply that the intrinsic activity of HBZ
is more important than the intestinal microbiota in influencing the immune modulation,
inflammation, and lymphomas observed in HBZ-Tg mice.
Fig 2. Comparison of T-cell subsets between HBZ-Tg and HBZ-Tg/IFN-γKOmice. (A and B)
Splenocytes were harvested fromWT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice at 24-week old. Cells
were stained with anti-CD4, anti-Foxp3, anti-CD25 antibodies for detection of regulatory T cells, and anti-
CD44, anti-CD62L antibodies for effector/memory CD4+ T cells. Percentages of each subset in CD4+ T cells
are shown (n = 3 or 4). TN: naïve T cell, TEM: effector/memory T cell. (C and D) Cytokine production in
CD4+Foxp3- T cells of each strain was evaluated. Splenocytes were stimulated with PMA/ionomycin in the
presence of protein transport inhibitor for 4 hours, stained with specific antibodies, and analyzed by flow
cytometry. Percentages of each subset in CD4+ T cells are shown (n = 3 or 4).
doi:10.1371/journal.ppat.1005120.g002
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CXCR3 and CXCL10 are not involved in HBZ-mediated inflammation
In a previous study, we showed that a chemokine receptor, CXCR3, was highly expressed on
HBZ-Tg CD4+ T cells and that most cells that had migrated into inflammatory lesions were
CXCR3 positive [18]. CXCR3 is expressed in IFN-γ-producing Th1 cells [22]. Thus we hypoth-
esized that the reduction of inflammation in HBZ-Tg/IFN-γ KOmice might correlate with
reduced CXCR3 expression on their CD4+ T cells. We compared CXCR3 expression levels
Fig 3. Inflammatory phenotypes of germ-free HBZ-Tgmice. (A) GF HBZ-Tg mice developed dermatitis similarly to SPF HBZ-Tg mice. (B) Splenocytes
were harvested from 18-week-old GF HBZ-Tg or GFWT littermates. The percentages of Tregs and effector/memory CD4+ T cells were evaluated.
Representative results of the dot plots and a summarized table are shown. (C) Cytokine production in CD4+ T cells was evaluated. Splenocytes were
stimulated with PMA/ionomycin in the presence of protein transport inhibitor for 4 hours, stained with specific antibodies, and analyzed by flow cytometry.
Representative results of the dot plots and a summarized table are shown.
doi:10.1371/journal.ppat.1005120.g003
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between HBZ-Tg and HBZ-Tg/IFN-γ KOmice, and found that HBZ-Tg/IFN-γ KOmice
expressed high levels of CXCR3 on CD4+ T cells despite of the absence of IFN-γ (Fig 4A).
Furthermore, we carried out chemotaxis assay to evaluate the function of CXCR3 expressed
on CD4+ T cells of HBZ-Tg and HBZ-Tg/IFN-γ KOmice. Murine recombinant CXCL10,
which is a major ligand of CXCR3, was used as a chemoattractant [22]. CD4+ T cells were puri-
fied from HBZ-Tg and HBZ-Tg/IFN-γ KOmice, and these cells were placed in the upper
chambers. The lower chambers were filled with media containing 200 or 500 ng/mL CXCL10
or control media. The migration capacity of CD4+ T cells from HBZ-Tg/IFN-γ KOmice was
similar as that from HBZ-Tg mice (Fig 4B). From these results, we conclude that CXCR3 was
inducible and functional in HBZ-Tg/IFN-γ KO mice.
Next, we evaluated the importance of CXCL10 in disease development in HBZ-Tg mice,
since CXCL10 is one of the chemokines induced by IFN-γ [23]. To do this, we established
HBZ-Tg/CXCL10 KO mice [24] (Fig 5A). HBZ-Tg/CXCL10 KO mice developed dermatitis
beginning at 12 weeks old (Fig 5B and 5C). At 24 weeks of age, about 80% of the mice had
developed dermatitis (Fig 5C). Histological analysis revealed that HBZ-Tg/CXCL10 KO mice
also developed inflammation in several other organs (Table 2). In addition, HBZ-Tg/CXCL10
KO mice showed increases in the numbers of Tregs and effector/memory fraction compared to
Fig 4. Expression and function of CXCR3 on CD4+ T cells in HBZ-Tg and HBZ-Tg/IFN-γ KOmice. (A)
Splenocytes were obtained frommice, and the CXCR3 expression level in CD4+ T cells was evaluated by
flow cytometry. Three mice of each strain were analyzed and the result was summarized in the graph. (B) The
migration activity of CD4+ T cells towards CXCL10. CD4+ T cells were isolated from splenocytes using
magnet beads. Murine recombinant CXCL10 was added at concentrations of 0, 200, or 500 ng/mL. Migrating
cells were counted by flow cytometry.
doi:10.1371/journal.ppat.1005120.g004
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WTmice (Fig 5D). All phenotypes of HBZ-Tg/CXCL10 KO mice we analyzed were quite simi-
lar to those of HBZ-Tg mice. We thus concluded that the CXCR3/CXCL10 axis was not related
to pathogenesis in our HBZ-Tg mouse model.
Identification of candidate molecules implicated in HBZ and IFN-γ
mediated pathogenesis
Although CD4+ T cells from HBZ-Tg mice and HBZ-Tg/IFN-γ KOmice were similar in their
migratory responses to CXCL10, their abilities to infiltrate tissues in vivo may differ, because
the HBZ-Tg/IFN-γ KOmice did not develop dermatitis to the same degree that the HBZ-Tg
mice did. Therefore we looked for chemokine receptors or adherent molecules that are highly
expressed on T cells in HBZ-Tg but not HBZ-Tg/IFN-γ KOmice. As shown in Fig 6A, most of
the molecules studied were highly expressed on CD4+ T cells of both HBZ-Tg and HBZ-Tg/
IFN-γ KOmice compared with wild type littermates. However, we found that the chemokine
receptor CCR9 was upregulated only in HBZ-Tg mice (Fig 6B), suggesting that upregulation of
CCR9 is involved in inflammation mediated by HBZ and IFN-γ.
Fig 5. CXCL10 is not associated with systemic inflammation in HBZ-Tgmice. (A) HBZ-Tg and CXCL10 KOmice were crossed to establish HBZ-Tg/
CXCL10 KOmice. (B) HBZ-Tg/CXCL10 KOmice developed dermatitis. (C) At 24 weeks old, more than 50% of HBZ-Tg/CXCL10 KOmice developed
dermatitis. (D) Splenocytes were obtained from CXCL10 KOmice and HBZ-Tg/CXCL10 KOmice. Cells were stained with anti-CD4, anti-CD44, anti-CD62L,
and anti-Foxp3, and analyzed by flow cytometry. Among CD4+ T cells of HBZ-Tg/CXCL10 KOmice there were increased numbers of increased effector/
memory and Foxp3 expressing cells.
doi:10.1371/journal.ppat.1005120.g005
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In order to identify further cellular genes implicated in HBZ/IFN-γ-mediated inflammation,
we performed DNA microarray analysis. We extracted RNA from CD4+ T cells of WT,
HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice and evaluated the profiles of gene expres-
sion. According to the result of microarray, we picked up several genes that were expressed
higher in HBZ-Tg than HBZ-Tg/IFN-γ KO, and validated their expression profiles by quanti-
tative RT-PCR. Among these genes, we further looked for the genes that are overexpressed in
human ATL cases. Finally, we identified Neo1, Il1f9, Fgfr4,Hip1, Iklf2, and Nrxn3 that met
these criteria (Fig 7A and 7B). Interestingly, human homologues of these genes were upregu-
lated especially in the aggressive form of ATL (Fig 7B). They are likely to be divided into 2
groups by the pattern of the expression in healthy donor cells. One contains the genes which
expression is unchanged or reduced in phytohaemagglutinin (PHA)-stimulated cells compared
with resting cells, such as NEO1, NRXN3, IKZF2, and HIP1. In contrast, IL1F9 and FGFR4
belong to another group in which their transcription are enhanced by PHA, suggesting that
they are inducible by potent mitogenic stimulation even in normal T cells. These genes were
generally overexpressed in HTLV-1-transformed and ATL cell lines although there were sev-
eral exceptions (S1 Table). Interestingly, it has been reported that most of them are aberrantly
expressed in several types of cancer cells, suggesting that they are associated with the linkage
between chronic inflammation and oncogenesis in HTLV-1-infected subjects.
Discussion
Persistent inflammation is widely recognized as a tumor-promoting factor in many cancers,
and it is estimated that about 15% of human malignancies are associated with chronic inflam-
mation and infection [25]. For example, inflammatory bowel diseases, such as ulcerative colitis,
are associated with colon cancer [26]. Chronic gastritis caused byHelicobacter pylori [27] and
chronic hepatitis caused by hepatitis B virus or hepatitis C virus [28] are implicated in develop-
ment of gastric cancer and hepatocellular carcinoma (HCC), respectively. In these solid
tumors, infiltrating immune cells are thought to produce cytokines, chemokines, and growth
Table 2. Histological findings in CXCL10 KO, and HBZ-Tg/CXCL10 KOmice at 24 weeks of age.
Dermatitis Spleen Lung Skin
CXCL10 KO #1 - - - -
#2 - - - -
#3 - - - -
#4 - - - -
#5 - - - -
#6 - - - -
#7 - - - -
#8 - - - -
HBZ-Tg/CXCL10 KO #1 - - - -
#2 - - - -
#3 + - + -
#4 + - + -
#5 + - - +
#6 +++ Atypical lymphocyte + +++
#7 +++ Atypical lymphocyte + ++
#8 +++ - + +
#9 ++ Atypical lymphocyte + +
doi:10.1371/journal.ppat.1005120.t002
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factors that induce the proliferation of tumor cells [25]. In addition, those inflammatory cells
produce reactive oxidative species resulting in genetic instability [29]. Activation of the TNF-α
or the NF-κB pathway is important especially in the development of HCC [30] and colon can-
cer [31].
In the case of HTLV-1 infection, the virus itself dysregulates the functions of CD4+ T cells,
modifies T-cell subsets, and triggers clonal expansion of infected cells. HTLV-1 causes both
inflammation and a malignant disease, but a precise mechanism crosslinking these diseases
was not clarified. Several clinical observations have suggested the correlation between HTLV-
1-associated inflammatory diseases and ATL. It was reported that the frequency of ATL devel-
opment in HTLV-1-infected patients with diffuse pan-bronchiolitis was significantly high
Fig 6. Expression of the chemokine receptors and adherent molecules on CD4+ T cells of WT,
HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice. (A) Splenocytes were stained with antibodies against
various chemokine receptors and adhesion molecules. The percentage of CD4+ T cells expressing each
molecule is shown. Three mice of each strain were analyzed. (B) The expression of CCR9 is significantly
upregulated in CD4+ T cells of HBZ-Tg but not in those of HBZ-Tg/IFN-γ KOmice.
doi:10.1371/journal.ppat.1005120.g006
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Fig 7. Microarray analysis of WT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γKOmice.CD4+ T cells were purified from splenocytes of WT, HBZ-Tg, IFN-γ KO,
and HBZ-Tg/IFN-γ KOmice. (A) Validation of the microarray result by qPCR. cDNA of splenocytes fromWT, HBZ-Tg, and HBZ-Tg/IFN-γ KOmice were
used. Expression levels of the candidate genes were normalized using the values of WT as reference. (B) Transcription levels of the human homologues of
the candidate genes in ATL patients and healthy donors (HD). Relative expression values were calculated by the delta delta Ct method using a value of one
resting sample as reference. Aggressive: acute and lymphoma types of ATL.
doi:10.1371/journal.ppat.1005120.g007
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among all HTLV-1 carriers [10]. In addition, the abundance of certain HTLV-1-infected clones
is increased in HTLV-1 carriers with strongyloides and infective dermatitis [11], implying that
these inflammatory diseases increase the risk of ATL development. In this study, we found T-
cell lymphomas only in HBZ-Tg mice with dermatitis, and severity of inflammation tended to
correlate with lymphoma development, suggesting that inflammatory signals induced by HBZ
accelerate oncogenic processes. Since there is no immune reaction against HBZ in these mice,
HBZ triggers inflammation only by its intrinsic action. This idea is compatible with the find-
ings that, even in a germ-free environment, the number of Tregs was increased in HBZ-Tg
mice and they developed systemic inflammation the same as under SPF conditions. These
results suggest that the inflammatory phenotypes of HBZ-Tg mice are caused by an inherent
function of HBZ, and that HBZ-mediated inflammation promotes oncogenesis in HBZ-
expressing CD4+ T cells.
In addition, we show here that IFN-γ is an important molecule in the pathogenesis by HBZ.
IFN-γ is conventionally recognized as a cytokine that acts in host defense against various path-
ogens and tumor rejection. IFN-γ is secreted by mainly activated CD4+ T cells (Th1 cells), cyto-
toxic CD8+ T lymphocytes, and natural killer cells, and has cytostatic/cytotoxic effects by
inducing cell-mediated immune responses [32]. IFN-γ primarily activates the JAK/STAT sig-
naling pathway through interaction with IFN-γR1, and induces the transcription of primary
response genes such as IRF family genes. Many of these primary response genes encode tran-
scription factors that induce a lot of secondary response genes to react to the stimulation. Pre-
vious studies showed that blockade of IFN-γ/IFN-γR signaling in mice compromised rejection
of tumors by the immune system, indicating that IFN-γ functions in immune surveillance
against tumors [33–35]. On the other hand, under certain circumstances, IFN-γ is also known
to have a protumorigenic function involving proliferative and anti-apoptotic signals in tumor
cells [32]. In this study, we found that knocking out of IFN-γ significantly decreased the inci-
dence of inflammation and malignant lymphoma in HBZ-Tg mice, indicating that IFN-γ plays
a supportive role in the development of both types of diseases caused by HBZ.
To understand how IFN-γ contributes to HBZ-associated pathogenesis, we looked for cellu-
lar factors differentially expressed in CD4+ T cells of HBZ-Tg compared with HBZ-Tg/IFN-γ
KOmice. These genes are thus implicated in pathogenesis mediated by HBZ and IFN-γ
together. CCR9 is an intestine oriented chemokine receptor [36]. This upregulation is consis-
tent with our observation that massive infiltration of lymphocytes was observed in HBZ-Tg
mice [18]. We also identified several cancer-related genes which are overexpressed in both
HBZ-Tg and ATL patients. NEO1 encodes a cell surface protein that belongs to the immuno-
globulin superfamily. It has been reported that overexpression of NEO1 in gastric cancer is
involved in cell proliferation and migration [37]. IL1F9, also known as IL36gamma, is an IFN-
γ-inducible gene that has been reported to activate NF-κB and MAPK signaling in human T
cells [38]. FGFR4 encodes a member of the fibroblast growth factor receptor family, and impli-
cated in the tumorigenesis of many types of cancers, such as HCC, prostate cancer, breast can-
cer, pancreatic cancer [39–43]. IKZF2 encodes a member of the Ikaros family of zinc-finger
proteins, Helios, which is mainly expressed in T cell. A recent study showed that aberrant iso-
forms of IKZF2 are dominantly expressed in ATL cells, and function in T-cell proliferation and
survival [44], suggesting that HBZ might dysregulate the expression pattern of IKZF2 in ATL
cells. HIP1 is also overexpressed in several cancer tissues like breast cancer and possesses the
oncogenic properties through BCL-2 and NF-κB pathways [45]. Taken together, it is possible
that HBZ and HBZ-mediated inflammation induce these factors and subsequently trigger
transformation in a part of HTLV-1-infected cells. In order to clarify the significance of each
factor in HBZ-mediated pathogenesis, further experiments will be required. Interestingly, pre-
vious studies on Tax, which is another oncoprotein of HTLV-1, showed that transgenic mice
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expressing Tax under control of the granzyme B promoter developed LGL leukemia, and
knocking out of IFN-γ in this strain enhanced the tumor formation [46, 47], suggesting that
IFN-γ has the opposite effect on Tax-mediated oncogenesis that it has on HBZ-mediated onco-
genesis. In these Tax-Tg mice, IFN-γ was shown to have an anti-angiogenic effect by suppress-
ing the transcription of VEGF [47]. HBZ and Tax regulate several signaling pathways in
opposite manners [1], suggesting that IFN-γmay differentially regulates the effects of HBZ and
Tax on HTLV-1-infected cells or HBZ and Tax may regulate IFN-γ in opposite way, in
response to the cellular context.
In HAM/TSP patients, IFN-γ-producing cells are increased in a CD4+FoxP3- subpopula-
tion, and suggested to have a role in the pathogenesis of this inflammatory disease [48, 49]. A
recent study showed that HTLV-1-infected cells in the cerebrospinal fluid expressed IFN-γ and
CXCR3, and its ligand CXCL10 was expressed in astrocytes upon stimulation with IFN-γ, lead-
ing to an IFN-γ-CXCL10-CXCR3 inflammatory loop [50]. In our HBZ-Tg mice, however,
CXCL10 is not associated with inflammation, since loss of CXCL10 didn’t affect the develop-
ment of inflammatory diseases. In addition, the upregulation of CXCR3 observed in HBZ-Tg
mice was independent of IFN-γ. Therefore CD4+ T cells from HBZ-Tg/IFN-γ KOmice still
expressed high levels of CXCR3, and could react to its ligand. According to these observations,
CXCL10/CXCR3 is unlikely to have strong effects on inflammation induced by HBZ. Indeed,
the expression of several other adherent molecules and chemokine receptors such as CCR4,
CD29, and CD49d, also showed the same pattern as CXCR3 (Fig 6). Induction of these mole-
cules is mediated by HBZ, but not associated with IFN-γ, suggesting that these molecules
might be involved in the inflammation that occurred late in HBZ-Tg/IFN-γ KOmice. Further
studies are needed to test this hypothesis.
In conclusion, we showed that IFN-γ, which is secreted by Th1-like cells such as exFoxp3
cells, has important roles in HBZ-mediated inflammation. HBZ increases the number of Tregs
in a cell intrinsic manner, and consequently induces IFN-γ in vivo. Importantly, inflammation
is closely linked to the development of malignant lymphomas in HBZ-Tg mice. This is the first
report showing the relationship between the immunomodulating function of HBZ and onco-
genesis that might explain the clinical observations of ATL development in HTLV-1-infected
subjects with chronic inflammations.
Materials and Methods
Mice
C57BL/6J mice were purchased from CLEA (Tokyo, Japan). Transgenic mice expressing the
spliced form of the HBZ gene under control of the mouse CD4 promoter have been described
previously [13, 16]. B6.129S7-Ifnγtm1Ts/J (Ifnγ-/-) [21] and B6.129S4-Cxcl10tm1Adl/J (Cxcl10-/-)
[24] mice were purchased from The Jackson Laboratory (CA, USA). Mice used in this study
were maintained under SPF conditions unless otherwise specified. GF HBZ-Tg and wild type
mice were reconstituted from frozen embryos and reared at the Central Institute for Experi-
mental Animals (Kawasaki, Japan). GF mice aged 18 weeks were transferred to Kyoto Univer-
sity, and analyzed within 24 hours.
Cell lines
HTLV-1-transformed cell lines (MT-2 and MT-4), ATL cell lines (MT-1, ED, TL-Om1, ATL-
43T+, and ATL-55T+) were cultured in RPMI 1640 medium supplemented with 10% fetal
bovine serum (FBS) and antibiotics at 37°C under a 5% CO2 atmosphere. For IL-2-dependent
cell lines (ATL-43T+ and ATL-55T+), recombinant human IL-2 (100 U/ml) was added in the
culture media.
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Clinical samples
Peripheral blood mononuclear cells (PBMCs) of ATL patients and healthy donors were col-
lected by Ficoll-Paque PLUS (GE Healthcare). To obtain PHA-stimulated cells, PBMCs were
treated with 10μg/ml PHA (Sigma) for 3 days.
Flow cytometric analysis
The following antibodies were used for flow cytometric analysis of mouse lymphocytes:
Anti-CD3e (145-2C11), CCR5 (C34-3448), IFN-γ (XMG1.2), IL-2 (JES6-5H4), IL-17
(TC11-18H10), CD29 (Ha2/5), CD49d (9C10), and CD162 (2PH1) antibodies were purchased
from BD Pharmingen. Anti-CD4 (RM4-5), CD8 (53–6.7), CD44 (IM7), CD62L (MEL-14),
CXCR3 (CXCR3-173), CCR4 (2G12), and TNF-α (MP6-XT22) antibodies were from Biole-
gend. Anti-CD25 (pc61), Foxp3 (FJK-16s), CCR9 (eBioCW-1.2), and IL-4 (11B11) antibodies
were from eBioscience. Anti-CCR10 antibody (248918) was purchased from R&D systems. In
order to stain cytokines, splenocytes were stimulated with 50ng/mL PMA (Nakarai Tesque),
1μg/mL ionomycin (Nakarai Tesque) and a protein transport inhibitor, BD Golgi plug (BD
Pharmingen) for 4 hours before harvesting cells. After cell surface staining, cells were fixed and
permeabilized with Fixation/Permeabilization working solution (eBioscience) and intracellular
antigens were stained. Flow cytometric analysis was carried out using a FACS Verse with FAC-
Suite software (BD Biosciences) and Flow Jo (FlowJo, LLC).
Histological analysis
Mouse tissues were fixed in 10% formalin in phosphate buffer (Nakarai Tesque) and then
embedded in paraffin. Hematoxylin and eosin staining was performed according to standard
procedures. Images were captured using a Provis AX80 microscope (Olympus) equipped an
OLYMPUS DP70 digital camera, and detected using a DP manager system (Olympus).
Migration assay
Mouse CD4+ T cells were isolated from splenocytes by CD4 T lymphocyte enrichment Set-DM
(BD Biosciences) and resuspended in RPMI containing 0.1% BSA. To evaluate migration activ-
ity, a Transwell insert (3.0um) (CORNING) was used. The lower chamber was filled with che-
motaxis medium containing mouse recombinant CXCL10 (R&D systems). One million cells
were added into the upper chamber. The chamber was incubated for 1 hour at 37C and 5%
CO2. Cells that migrated towards CXCL10 were counted using Flow cytometry.
Microarray analysis
CD4+ T cells were isolated fromWT, HBZ-Tg, IFN-γ KO and HBZ-Tg/IFN-γ KOmice as
described above and lysed in TRIzol (Life Technologies). Total RNAs were extracted from
these lysates with Direct-zol RNAMiniPrep (Zymo Research). RNA quality was checked using
Agilent 2100 Bioanalyzer (Agilent Technologies). Microarray experiments were carried out
with SurePrint G3 Mouse GE 8x60K (Agilent Technologies) according to manufacturer’s
instructions. Data was analyzed with GeneSpring GX software (Agilent Technologies).
Quantitative RT-PCR
Splenocytes harvested fromWT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice and
human PBMCs obtained from ATL patients and healthy donors were lysed with TRIzol
reagent, and RNA was extracted as described above. cDNAs were synthesized from 1μg of total
RNAs using random primers and SuperScript III Reverse Transcriptase (Life Technologies).
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The expression levels of candidate genes were quantified by the StepOnePlus real time PCR
system (Life Technologies) using FastStart Universal SYBR Green Master (Roche). Relative
expression levels of each gene were calculated by the delta delta Ct method [51]. The sequences
of primers used in this study are listed in S2 Table. Human NRXN3 was quantified using Taq-
man Gene Expression Assays (Applied Biosystems, Hs01028186_m1).
Ethics statement
Animal experiments were performed in strict accordance with the Japanese animal welfare
bodies (Law No. 105 dated 19 October 1973 modified on 2 June 2006), and the Regulation on
Animal Experimentation at Kyoto University. The protocol was approved by the Institutional
Animal Research Committee of Kyoto University (Permit numbers are D13-02, D14-02, and
D15-02). Experiments using clinical samples were conducted according to the principles
expressed in the Declaration of Helsinki, and approved by the Institutional Review Board of
Kyoto University (Permit numbers are G310 and G204). ATL patients provided written
informed consent for the collection of samples and subsequent analysis.
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S1 Fig. Genotyping of HBZ-Tg/IFN-γ KOmice. Genotyping of WT, HBZ-Tg, IFN-γ KO,
and HBZ-Tg/IFN-γ KOmice was carried out by PCR.
(PPTX)
S2 Fig. Representative dot plots of T-cell subsets in HBZ-Tg and HBZ-Tg/IFN-γ KOmice.
(A) Splenocytes were harvested fromWT, HBZ-Tg, IFN-γ KO, and HBZ-Tg/IFN-γ KOmice
at 24-week old. Cells were stained with anti-CD4, anti-Foxp3, anti-CD25 antibodies for detec-
tion of regulatory T cells, and anti-CD44, anti-CD62L antibodies for effector/memory CD4+ T
cells. Representative results are shown. (B) Cytokine production in CD4+ T cells was evaluated.
Splenocytes were stimulated with PMA/ionomycin in the presence of protein transport inhibi-
tor for 4 hours, stained with specific antibodies, and analyzed by flow cytometry. Representa-
tive results are shown.
(PPTX)
S3 Fig. Inflammatory phenotypes of SPF HBZ-Tg mice. (A) Splenocytes were harvested
from 18-week-old SPF HBZ-Tg or SPF WT littermates. The percentages of Tregs and effector/
memory CD4+ T cells were evaluated. Representative results of the dot plots and a summarized
table are shown. (B) Cytokine production in CD4+ T cells was evaluated. Splenocytes were
stimulated with PMA/ionomycin in the presence of protein transport inhibitor for 4 hours,
stained with specific antibodies, and analyzed by flow cytometry. Representative results of the
dot plots and a summarized table are shown.
(PPTX)
S1 Table. Quantification of the candidate genes in HTLV-1-infected cell lines. Each value
was calculated by the delta delta Ct method using a resting HD sample as reference. N.D.: not
detected.
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S2 Table. Primers for quantitative RT-PCR.
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